| Customization: | Available |
|---|---|
| Varieties: | Growth Promoting Medicine |
| Component: | Chemical Synthetic Drugs |
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Enrofloxacin injection 12% is a broad-spectrum antibiotic. Although the mechanism of action is not well-understood, Enrofloxacin is effective against a broad spectrum of gram- positive and gram-negative bacteria including most species of the following: Pseudomonas aeruginosa, Klebsiella, li., Enterobacter, Campylobacter, Shigella, Salmonella, Aeromonas, Haemophillus, Proteus, Yersinia, Serratia, Vibrio, Brucella, Chlamydia, Staphylocci (including some methicillin resistant strains), Mycoplasma and Mycobacterium. It is not effective against anaerobic bacteria and may be variably effective against Streptococcus infections. Enrofloxacin has a similar spectrum of activity as ciprofloxacin but enrofloxacin has been shown to have better bioavailability. With the exception of cerebral-spinal fluid, enrofloxacin attains therapeutic levels in most tissues of the body. This makes it a very attractive antibiotic choice for difficult-to-treat infections, particularly those that need long-term antibiotics. Some examples might be osteomyelitis, sinus infections, otitis, difficult soft-tissue infections, peritonitis, and pleuritis or pneumonia.
Enrofloxacin is eliminated by both renal and hepatic metabolism. Animals with impaired kidney or liver function may need extra monitoring and dose adjustments to prevent excess drug accumulation.
){kind=link}